商务合作
动脉网APP
可切换为仅中文
Digital health company Liva Healthcare has acquired UK-based Momenta, a provider of digital, virtual, and in-person healthy lifestyle programmes, for an undisclosed sum.
数字健康公司Liva Healthcare以未披露的金额收购了英国Momenta公司,后者提供数字化、虚拟和面对面的健康生活方式项目。
At the same time, the Copenhagen and London-based company has raised additional financing that will be used to accelerate its growth and international expansion, led by Danish investment company IBL Group.
与此同时,这家总部位于哥本哈根和伦敦的公司已获得额外融资,由丹麦投资公司IBL Group领投,将用于加速其增长和国际扩张。
The amount of funding – which is backed by existing investors MIG, Santos, Maj Invest and other private investors – is also not being revealed.
这笔资金的数额——由现有投资者MIG、Santos、Maj Invest及其他私人投资者支持——也未对外公布。
Liva offers app-based, one-on-one, healthy lifestyle coaching programmes to help people better manage their weight and lifestyle-related chronic conditions like type 2 diabetes and cardiovascular disease, and its platform is already being used by the NHS in England after being
Liva提供基于应用程序的一对一健康生活方式指导计划,帮助人们更好地管理体重以及与生活方式相关的慢性疾病,如2型糖尿病和心血管疾病,其平台已被英格兰国家医疗服务体系(NHS)采用。
backed
支持;赞助;背书
by health technology assessment organisation NICE.
由卫生技术评估组织NICE发布。
Momenta operates in the same area, providing programmes to the NHS, local authorities and other organisation in the UK. Its range of behavioural intervention programmes covers cardiovascular disease prevention, management of diabetes, help losing weight, smoking cessation, healthy eating and exercise referral..
Momenta在同一领域运营,为英国的NHS、地方政府和其他组织提供项目。其一系列行为干预项目涵盖心血管疾病预防、糖尿病管理、减肥帮助、戒烟、健康饮食和运动指导。
The acquisition by Liva includes Momenta Newcastle, which delivers the programmes developed by Discover Momenta.
Liva的收购包括Momenta Newcastle,该公司负责交付Discover Momenta开发的课程。
Liva – which already operates in several European markets including the UK, Germany, Denmark, Spain, and Sweden as well as in Asia-Pacific countries, said in a statement that the acquisition will increase its reach.
Liva——已在包括英国、德国、丹麦、西班牙和瑞典等欧洲市场以及亚太地区国家开展业务——在一份声明中表示,此次收购将扩大其业务范围。
It has a partnership with UK retail pharmacy chain Boots to provide weight management programmes to patients who use Boots Online Doctor, a telehealth service that provides online consultations and medicine prescriptions, as well as at-home test kits, covering dozens of common healthcare conditions..
它与英国零售药房连锁店Boots合作,为使用Boots Online Doctor的患者提供体重管理计划。Boots Online Doctor是一项远程医疗服务,提供在线咨询和药物处方,以及数十种常见健康状况的家庭检测套件。
That includes patients who access GLP-1 weight loss drugs like Eli Lilly's Mounjaro (tirzepatide) and Novo Nordisk's Wegovy (semaglutide) on prescription via Boots' Online Doctor. Liva provides the weight loss/healthy lifestyle coaching elements of the service.
这包括那些通过Boots在线医生处方获得GLP-1减肥药物(如礼来的Mounjaro(替西帕肽)和诺和诺德的Wegovy(司美鲁肽))的患者。Liva提供减肥/健康生活方式的教练服务。
It is also part of a consortium of EU bodies, led by pharma group Amgen, that developed a digital cardiac rehabilitation programme called Rehab+.
它也是一个由制药集团安进领导的欧盟机构联盟的一部分,该联盟开发了一个名为Rehab+的数字心脏康复项目。
Liva chief executive Shahram Sharif said the acquisition 'marks a step-change in Liva's ambitions, as we embark on a revamped strategic growth plan to help more people prevent, manage and reverse their chronic conditions' and 'cements Liva's position as one of the largest providers of such services to the NHS in England.'.
Liva首席执行官Shahram Sharif表示,此次收购“标志着Liva在雄心壮志上迈出了重要一步,我们正在实施一项全新的战略增长计划,以帮助更多人预防、管理和逆转他们的慢性病”,并“巩固了Liva作为英格兰NHS此类服务最大提供商之一的地位”。